Insulin-dependent suppression of cholesterol 7α-hydroxlase is a possible link between glucose and cholesterol metabolisms

Cholesterol 7α-hydroxylase (CYP7A1) regulates the balance between cholesterol supply and metabolism by catalyzing the rate-limiting step of bile acid biosynthesis. The transcriptional activity of CYP7A1 is tightly controlled by various nuclear receptors. A forkhead transcription factor O1 (FOXO1) plays a critical role in metabolism, and insulin inactivates FOXO1 through Akt-dependent phosphorylation and nuclear exclusion. We investigated the role of insulin-Akt-FOXO1 signaling pathway in CYP7A1 transcriptional regulation since we found putative insulin-response elements, FOXO1 binding sequences, in both rat and human CYP7A1 promoters. However, ectopic expression of FOXO1 increased the rat CYP7A1-, but mildly reduced human CYP7A1-promoter activities in a dose-dependent manner. Similarly to bile acids, insulin treatment increased small heterodimer partner (SHP) mRNA rapidly and transiently, leading to the suppression of CYP7A1 transcription in both human and rodents. Chromatin immunoprecipitation showed that FOXO1 directly bound to rat CYP1A1 promoter in the absence of insulin. FOXO1 binding to the rat promoter was diminished by insulin treatment as well as by expression of SHP. Our results suggest that the stimulation of insulin- signaling pathway of Akt-FOXO1 and SHP expression may regulate cholesterol/bile acid metabolisms in liver, linking carbohydrate and cholesterol metabolic pathways. A prolonged exposure of insulin in hyperinsulinemic insulin resistance or diabetic status represses CYP7A1 transcription and bile acid biosynthesis through SHP induction and FOXO1 inactivation, leading to impairment of the hepatic cholesterol/bile acid metabolisms.

[1]  T. Hunter,et al.  Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[2]  C. Slaughter,et al.  Cloning and regulation of cholesterol 7 alpha-hydroxylase, the rate-limiting enzyme in bile acid biosynthesis. , 1990, The Journal of biological chemistry.

[3]  S. Farmer.  The forkhead transcription factor Foxo1: a possible link between obesity and insulin resistance. , 2003, Molecular cell.

[4]  G. Gil,et al.  Role of FXR and FTF in bile acid-mediated suppression of cholesterol 7alpha-hydroxylase transcription. , 2000, Nucleic acids research.

[5]  T. Kitamura,et al.  Role of FoxO Proteins in Pancreatic β Cells , 2007 .

[6]  T. A. Kerr,et al.  Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. , 2000, Molecular cell.

[7]  B. Burgering,et al.  Stressing the role of FoxO proteins in lifespan and disease , 2007, Nature Reviews Molecular Cell Biology.

[8]  K. Mitropoulos,et al.  Cholesterol 7 alpha-hydroxylase. , 1977, Journal of lipid research.

[9]  T. Kitamura,et al.  Role of FoxO Proteins in Pancreatic beta Cells. , 2007, Endocrine journal.

[10]  In-kyu Lee,et al.  Differential Regulation of Human and Mouse Orphan Nuclear Receptor Small Heterodimer Partner Promoter by Sterol Regulatory Element Binding Protein-1* , 2004, Journal of Biological Chemistry.

[11]  Richard N Redinger,et al.  The coming of age of our understanding of the enterohepatic circulation of bile salts. , 2003, American journal of surgery.

[12]  M. Hoekman,et al.  Insulin suppresses bile acid synthesis in cultured rat hepatocytes by down‐regulation of cholesterol 7α‐hydroxylase and sterol 27‐hydroxylase gene transcription , 1995, Hepatology.

[13]  T. Osborne,et al.  PGC-1alpha activates CYP7A1 and bile acid biosynthesis. , 2003, The Journal of biological chemistry.

[14]  J. Chiang,et al.  Nuclear receptor-mediated repression of human cholesterol 7alpha-hydroxylase gene transcription by bile acids. , 2001, Journal of lipid research.

[15]  T. Unterman,et al.  FoxO proteins in insulin action and metabolism , 2005, Trends in Endocrinology & Metabolism.

[16]  S. Kliewer,et al.  Differential regulation of rat and human CYP7A1 by the nuclear oxysterol receptor liver X receptor-alpha. , 2003, Molecular endocrinology.

[17]  Hiroyuki Aburatani,et al.  Skeletal Muscle FOXO1 (FKHR) Transgenic Mice Have Less Skeletal Muscle Mass, Down-regulated Type I (Slow Twitch/Red Muscle) Fiber Genes, and Impaired Glycemic Control*[boxs] , 2004, Journal of Biological Chemistry.

[18]  K. Heidenreich,et al.  FoxO1 Regulates Multiple Metabolic Pathways in the Liver , 2006, Journal of Biological Chemistry.

[19]  T. Osborne,et al.  FGF15/FGFR4 Integrates Growth Factor Signaling with Hepatic Bile Acid Metabolism and Insulin Action* , 2009, Journal of Biological Chemistry.

[20]  Bhaskar Ponugoti,et al.  Functional interaction of hepatic nuclear factor-4 and peroxisome proliferator-activated receptor-gamma coactivator 1alpha in CYP7A1 regulation is inhibited by a key lipogenic activator, sterol regulatory element-binding protein-1c. , 2007, Molecular endocrinology.

[21]  A. Fukamizu,et al.  Bile Acids Regulate Gluconeogenic Gene Expression via Small Heterodimer Partner-mediated Repression of Hepatocyte Nuclear Factor 4 and Foxo1* , 2004, Journal of Biological Chemistry.

[22]  J. Xu,et al.  Foxo1 mediates insulin action on apoC-III and triglyceride metabolism. , 2004, The Journal of clinical investigation.

[23]  T. Osborne,et al.  PGC-1α Activates CYP7A1 and Bile Acid Biosynthesis* , 2003, Journal of Biological Chemistry.

[24]  Jae Hoon Jeong,et al.  Sterol-independent repression of low density lipoprotein receptor promoter by peroxisome proliferator activated receptor γ coactivator-1α (PGC-1α) , 2009, Experimental & Molecular Medicine.

[25]  In-kyu Lee,et al.  Orphan nuclear receptor small heterodimer partner inhibits angiotensin II-stimulated PAI-1 expression in vascular smooth muscle cells , 2010, Experimental & Molecular Medicine.

[26]  S. Nishikawa,et al.  Abnormal Angiogenesis in Foxo1 (Fkhr)-deficient Mice* , 2004, Journal of Biological Chemistry.

[27]  Jerry Donovan,et al.  Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. , 2003, Nature.

[28]  K. Guan,et al.  Negative Regulation of the Forkhead Transcription Factor FKHR by Akt* , 1999, The Journal of Biological Chemistry.

[29]  S. Strom,et al.  Insulin regulation of cholesterol 7alpha-hydroxylase expression in human hepatocytes: roles of forkhead box O1 and sterol regulatory element-binding protein 1c. , 2006, The Journal of biological chemistry.

[30]  L. Moore,et al.  A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. , 2000, Molecular cell.

[31]  Min-Seon Kim,et al.  Role of hypothalamic Foxo1 in the regulation of food intake and energy homeostasis , 2006, Nature Neuroscience.

[32]  S. Goodart,et al.  Mice Expressing the Human CYP7A1 Gene in the Mouse CYP7A1 Knock-out Background Lack Induction of CYP7A1 Expression by Cholesterol Feeding and Have Increased Hypercholesterolemia When Fed a High Fat Diet* , 2002, The Journal of Biological Chemistry.

[33]  Bruce M. Spiegelman,et al.  Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction , 2003, Nature.

[34]  D. Moore,et al.  Forkhead box transcription factor O1 inhibits cholesterol 7alpha-hydroxylase in human hepatocytes and in high fat diet-fed mice. , 2009, Biochimica et biophysica acta.

[35]  T. Taniguchi,et al.  Characterization of Hepatic-specific Regulatory Elements in the Promoter Region of the Human Cholesterol 7α-Hydroxylase Gene* , 1997, The Journal of Biological Chemistry.